Arrowhead Pharmaceuticals (ARWR) EPS (Basic) (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted EPS (Basic) of -$0.97 for Q1 2026, down 568.72% on a QoQ basis from $0.21 in Q4 2025, and down 135.02% year-over-year from $2.76 in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) EPS (Basic) (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.97 for Q1 2026.
- Quarterly EPS (Basic) fell 135.02% year-over-year to -$0.97 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.91 (down 64.62% YoY) and the FY2025 annual result came in at $0.23, up 104.42% from the prior year.
- EPS (Basic) was -$0.97 for Q1 2026 at Arrowhead Pharmaceuticals, down from $0.21 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.76 in Q1 2025 and bottomed at -$1.45 in Q3 2024.
- A 5-year average of -$0.51 and a median of -$0.97 in 2026 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) plunged 330.66% — and 2025, when it jumped 367.78%.
- Arrowhead Pharmaceuticals' EPS (Basic) stood at -$0.39 in 2022, then plunged by 219.76% to -$1.26 in 2023, then fell by 11.36% to -$1.4 in 2024, then soared by 114.68% to $0.21 in 2025, then sank by 568.72% to -$0.97 in 2026.
- Business Quant data shows ARWR's EPS (Basic) at -$0.97 in Q1 2026, $0.21 in Q4 2025, and $0.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Arrowhead Pharmaceuticals | 12.14 Bn | 10.36 Bn | - | -0.97 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.97 |
| Dec 31, 2025 | 0.21 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | -1.29 |
| Mar 31, 2025 | 2.76 |
| Dec 31, 2024 | -1.40 |
| Sep 30, 2024 | -1.45 |
| Jun 30, 2024 | -1.40 |
| Mar 31, 2024 | -1.03 |
| Dec 31, 2023 | -1.26 |
| Sep 30, 2023 | -1.04 |
| Jun 30, 2023 | -0.97 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | -0.39 |
| Sep 30, 2022 | -0.82 |
| Jun 30, 2022 | -0.68 |
| Mar 31, 2022 | 0.42 |
| Dec 31, 2021 | -0.60 |
| Sep 30, 2021 | -0.61 |
| Jun 30, 2021 | -0.29 |